Industry Insights: Navigating the Complex Specialty Pharmacy Landscape

Integrated health system specialty pharmacies improve medication access, enhance treatment plan adherence, and support better outcomes.

By Lindsey DeMarrais

Date

March 28, 2025

Read Time

3 minutes

Integrated health system specialty pharmacies improve medication access and enhance treatment plan adherence. By bringing specialty pharmacy into their portfolio, health systems can deliver high-touch support throughout a patient’s care journey and enable better patient outcomes. While clearly beneficial to patients and the health system overall, operating and optimizing a specialty pharmacy presents unique challenges that hospitals and health systems should be prepared to address.

Lindsey DeMarrais, PharmD, MS, Managing Pharmacist Consultant with McKesson’s Professional & Advisory Services (P&AS) team, recently shared her thoughts on how health systems can thrive in navigating the complex specialty pharmacy landscape with MedCity News. Read the full article here.

To learn more about partnering with McKesson to achieve more with your specialty pharmacy strategy, contact us today.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Industry Insights: Navigating the Complex Specialty Pharmacy Landscape

Related Stories

Related Tags